GE HealthCare Technologies Inc. (GEHC) Stock
GE HealthCare stock price chart
GEHC stock quote & key statistics
GE HealthCare annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $20.62B | $2.08B | $4.58 |
| FY2024 | $19.67B | $1.99B | $4.61 |
| FY2023 | $19.55B | $3.10B | $3.94 |
| FY2022 | $18.34B | $1.92B | $4.22 |
| FY2021 | $17.59B | $2.25B | — |
Fiscal year ending December 31. Source: company filings via EODHD.
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc., headquartered in Chicago, Illinois, specializes in the development, manufacturing, and global marketing of a wide range of products, services, and digital solutions essential for the diagnosis, treatment, and monitoring of patients worldwide. The company operates through four distinct segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics, each focusing on specific aspects of medical technology innovation.
Within the Imaging segment, GE HealthCare Technologies offers advanced solutions including molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and specialized products for women's health. The Ultrasound segment provides medical devices tailored for screening, diagnosis, and treatment across various clinical disciplines such as radiology, primary care, cardiovascular health, and women's health, alongside surgical visualization and guidance technologies.
The Patient Care Solutions segment enhances healthcare delivery through a portfolio of medical devices, consumables, services, and digital healthcare solutions. This segment includes patient monitoring systems, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal-infant care products, and comprehensive service offerings. Additionally, the Pharmaceutical Diagnostics segment supplies essential diagnostic agents for CT, MR, X-ray, and nuclear medicine imaging, including contrast media pharmaceuticals and molecular imaging agents. With a focus on continuous innovation and strategic partnerships, such as its collaboration with Mass General Brigham in artificial intelligence, GE HealthCare Technologies remains at the forefront of advancing medical technology to improve patient outcomes globally.
GE HealthCare stock FAQ
What is the GE HealthCare stock ticker symbol?
GE HealthCare Technologies Inc. trades on the NASDAQ under the ticker symbol GEHC.
What sector and industry is GE HealthCare in?
GE HealthCare Technologies Inc. is classified in the Healthcare sector, Medical Devices industry.
How many employees does GE HealthCare have?
GE HealthCare Technologies Inc. has about 54,000 full-time employees.
What were GE HealthCare's revenue and earnings last fiscal year?
GE HealthCare reported revenue of $20.62B and net income of $2.08B in fiscal 2025, with earnings per share of $4.58. Revenue grew 4.8% from the prior year.
Is GE HealthCare in the Nasdaq-100?
Yes. GE HealthCare Technologies Inc. (GEHC) is a component of the Nasdaq-100 index, which tracks the largest non-financial companies listed on the Nasdaq Stock Market.
Is GE HealthCare in the S&P 500?
Yes. GE HealthCare Technologies Inc. (GEHC) is a component of the S&P 500, the index of 500 leading U.S. companies widely used as a benchmark for the U.S. stock market.
Is GE HealthCare in the Russell 1000?
Yes. GE HealthCare Technologies Inc. (GEHC) is a component of the Russell 1000, which tracks roughly the 1,000 largest U.S. companies.
When did GE HealthCare go public?
GE HealthCare stock began trading on January 4, 2023.